<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html id="q166i8079"><head id="u935l6426"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" id="y910g9473"><title id="w520g7883">Craig Jordan and Ponder: Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy</title><link rel="stylesheet" type="text/css" href="jats-preview.css" id="w77v3724"></head><body id="e924v7584">
      <div id="article1-front" class="front">
         <div class="metadata two-column table" id="g695n3698">
            <div class="row" id="o803e8996">
               <div class="cell" id="v312o1011">
                  <h4 class="generated" id="r967z9940">Journal Information</h4>
                  <div class="metadata-group" id="b531j6950">
                     <p class="metadata-entry" id="p212w126"><span class="generated" id="r159a8167">Journal ID (<span class="data" id="b545d4222">nlm-ta</span>): </span>Breast Cancer Res
                     </p>
                     <p class="metadata-entry" id="t633r1025"><span class="generated" id="b291c7976">Title: </span>Breast Cancer Research
                     </p>
                     <p class="metadata-entry" id="h911a2250"><span class="generated" id="u441d8200">ISSN (<span class="data" id="q173f9599">print</span>): </span>1465-5411
                     </p>
                     <p class="metadata-entry" id="q609e2491"><span class="generated" id="p333g5318">ISSN (<span class="data" id="e8r265">electronic</span>): </span>1465-542X
                     </p>
                     <p class="metadata-entry" id="t902e8098"><span class="generated" id="v926j2129">Publisher: </span>BioMed Central<span class="generated" id="p911q8922"> (</span>London<span class="generated" id="a207o4415">)</span></p>
                  </div>
               </div>
               <div class="cell" id="n588r4186">
                  <h4 class="generated" id="u455w7452">Article Information</h4>
                  <div class="metadata-group" id="h236u9986">
                     <p class="metadata-entry" id="e168n8675"><span class="generated" id="u102l4580">External link: </span><a target="xrefwindow" href="http://breast-cancer-research.com/content/5/6/281" id="d1e81">http://breast-cancer-research.com/content/5/6/281</a></p>
                     <p class="metadata-entry" id="n665m114"><span class="generated" id="a683x1050">Copyright statement: </span>Copyright &copy; 2003 BioMed Central Ltd
                     </p>
                     <p class="metadata-entry" id="o832g8551"><span class="generated" id="d65d4396">Publication date (<span class="data" id="w105r3970">print</span>): </span>2003
                     </p>
                     <p class="metadata-entry" id="h972a1115"><span class="generated" id="y424f8729">Publication date (<span class="data" id="y922s3494">electronic</span>): </span>26 August 2003
                     </p>
                     <p class="metadata-entry" id="d86w8320"><span class="generated" id="o242a2925">Volume: </span>5
                     </p>
                     <p class="metadata-entry" id="n274q8286"><span class="generated" id="o712z7275">Issue: </span>6
                     </p>
                     <p class="metadata-entry" id="h574j9463"><span class="generated" id="v726r7411">Pages: </span>281-283
                     </p>
                     <p class="metadata-entry" id="x814e8270"><span class="generated" id="q199u4786">PubMed ID: </span>14580241
                     </p>
                     <p class="metadata-entry" id="c839h8819"><span class="generated" id="t584z6696">Article Id (<span class="data" id="i737u6483">pmc</span>): </span>314406
                     </p>
                     <p class="metadata-entry" id="b110n8410"><span class="generated" id="i46p805">Publisher ID: </span>bcr646
                     </p>
                  </div>
               </div>
            </div>
         </div>
         <hr class="part-rule" id="c953j4688"><div class="metadata centered" id="e954z8737">
            <h1 class="document-title" id="b819w389">Introducing a new section to <i id="x706p597">Breast Cancer Research</i>: Endocrinology and hormone therapy
            </h1>
         </div>
         <div class="metadata two-column table" id="o332o9791">
            <div class="row" id="s889w424">
               <div class="cell" style="text-align: right" id="v707t4619">
                  <div class="metadata-group" id="a989l4325">
                     <p class="metadata-entry" id="k203g8023"><a id="d1e37">
                           <!-- named anchor --></a>V Craig Jordan<span class="generated" id="b260e4019">[</span><a href="#I1" id="p281m978">1</a><span class="generated" id="a284m8644">]</span></p>
                  </div>
               </div>
               <div class="cell" id="e768k207">
                  <div class="metadata-group" id="p513i8765">
                     <p class="metadata-entry" id="a862o5580"><span class="generated" id="n957l8142">Email: </span><a href="mailto:vcjordan@northwestern.edu" id="r27o9101">vcjordan@northwestern.edu</a></p>
                  </div>
               </div>
            </div>
         </div>
         <div class="metadata two-column table" id="i688y8448">
            <div class="row" id="w949x3935">
               <div class="cell" style="text-align: right" id="s905t2804">
                  <div class="metadata-group" id="a373g7926">
                     <p class="metadata-entry" id="z323q790"><a id="d1e47">
                           <!-- named anchor --></a>Bruce AJ Ponder<span class="generated" id="b255w3114">[</span><a href="#I2" id="j512r4574">2</a><span class="generated" id="d114w7709">]</span></p>
                  </div>
               </div>
               <div class="cell" id="b860d3946">
                  <div class="metadata-group" id="c869m1430"></div>
               </div>
            </div>
         </div>
         <div class="metadata two-column table" id="q259w6360">
            <div class="row" id="g164b7716">
               <div class="cell empty" id="a513g253"></div>
               <div class="cell" id="k330h4693">
                  <div class="metadata-group" id="z840m3563">
                     <p class="metadata-entry" id="v380u5272"><a id="I1">
                           <!-- named anchor --></a><span class="generated" id="t202k3283">[</span>1<span class="generated" id="e921l1054">] </span>Diana, Princess of Wales Professor of Cancer Research, Director, Lynn Sage Breast Cancer Research Program, Northwestern University
                        Medical School, Chicago, Illinois, USA
                     </p>
                     <p class="metadata-entry" id="g609v2931"><a id="I2">
                           <!-- named anchor --></a><span class="generated" id="b898l9314">[</span>2<span class="generated" id="s373s1524">] </span>Head of CRC Department of Oncology, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, UK
                     </p>
                  </div>
               </div>
            </div>
         </div>
         <hr class="section-rule" id="w243z8835"><div class="metadata two-column table" id="m610o3564">
            <div class="row" id="v655n4689">
               <div class="cell" style="text-align: right" id="k751w5230">
                  <h4 class="callout-title" id="e612m98"><span class="generated" id="i159a7755">Abstract</span></h4>
               </div>
               <div class="cell" id="u782y6713">
                  <p class="first" id="d1e85">Endocrine therapy is increasingly understood as the conceptual basis for the future treatment and prevention of breast cancer.
                     Endocrine agents have considerably changed the approach to targeted treatment during the past two decades, and select endocrine
                     agents have advanced the goal of preventing breast cancer. Progress has occurred because of a vigorous interaction between
                     laboratory scientists and the clinical trials community. <i id="n801y1110">Breast Cancer Research </i>is launching a new section on endocrinology and hormone therapy in order to invigorate this exchange and challenge our readers
                     with novel concepts that might result in enhanced survival in breast cancer.
                  </p>
               </div>
            </div>
         </div>
         <hr class="part-rule" id="w141x6401"></div>
      <div id="article1-body" class="body">
         <div class="section" id="h468k5198"><a id="d1e100">
               <!-- named anchor --></a><h2 class="main-title" id="q168z6682">Introduction</h2>
            <p id="d1e103">Endocrine therapy is increasingly understood as the conceptual basis for the future treatment and prevention of breast cancer.
               Endocrine agents have considerably changed the approach to targeted treatment during the past two decades, and select endocrine
               agents have advanced the goal of preventing breast cancer. Progress has been made because of a vigorous interaction between
               laboratory scientists and the clinical trials community. The result is that hundreds of thousands of women who would have
               died now live longer, healthier lives. <i id="x849l879">Breast Cancer Research </i>is therefore launching a new section on endocrinology and hormone therapy to invigorate this exchange and challenge our readers
               with novel concepts that might result in enhanced survival in breast cancer.
            </p>
            <p id="d1e108">As we have done previously in areas of special interest to the breast cancer community, we will mark the new section with
               a series of thematic reviews on the evolution of progress in endocrine therapy. One of these reviews will focus on antioestrogens
               and aromatase inhibitors. The ubiquitous application of the antioestrogen tamoxifen since the 1970s has radically improved
               the prospects for breast cancer patients and, as a result, it has generated enormous interest in new approaches to targeted
               therapy. All earlier antioestrogens or aromatase inhibitors failed to become accepted into general use because of excessive
               toxicity that prevented long-term administration. The evolving clinical trials ultimately demonstrated that, to save lives,
               long-term administration over 5 years is required [<a href="#B1" id="i774e4567">1</a>]. However, key to the remarkable advances in endocrine therapy was the identification of the oestrogen receptor (ER) as the
               mechanism and catalyst for universal oestrogen action. Fortunately, the ER represents a critical growth and survival pathway
               in breast tumours, and so blocking the ER with an antioestrogen is selectively toxic to the tumour. The ER thus became an
               early model for molecular medicine [<a href="#B2" id="l381y6715">2</a>]. Today, endocrine agents that exploit the ER target in one way or another are ubiquitous in medicine, with clinical studies
               of the use of aromatase inhibitors at all stages of ER-positive breast cancer [<a href="#B3" id="s388v7530">3</a>] and testing of selective oestrogen receptor modulators (SERMs) to prevent breast cancer, osteoporosis and coronary heart
               disease.
            </p>
            <p id="d1e119">We will also discuss the effect of hormone replacement therapy (HRT) on breast cancer. Large clinical studies have demonstrated
               that there is a significant reduction in osteoporotic fractures and, paradoxically, colon cancer in women who use oestrogen
               plus progestin replacement (HRT), but there is an unacceptable increase in breast cancer, dementia, cardiovascular disease
               and clotting episodes [<a href="#B4" id="j824x6307">4</a>,<a href="#B5" id="b637r4336">5</a>]. The discovery of new designer oestrogens or SERMs has now become a priority in medicine, and there are opportunities to
               develop new progestins. The goal is to improve quality of life without carcinogenic potential.
            </p>
            <p id="d1e127">Another review may look at the new trend in antihormone or SERM therapy and endocrine drug resistance. The use of SERMs to
               prevent breast cancer, osteoporosis or coronary heart disease will not necessarily be limited to 5 years of treatment, but
               long-term use may increase the potential to develop endocrine-resistant breast cancer. Thus, the challenge for the future
               is fast becoming how to address endocrine drug resistance and the identification of novel targets to treat tumours resistant
               to SERMs. Not surprisingly, extended endocrine therapy eventually results in drug resistance but, uniquely, SERM-stimulated
               breast tumour growth continues to depend on the ER in the signal transduction pathway. A pure antioestrogen, that retargets
               and destroys the ER, is already available as a new second line treatment for tamoxifen-resistant breast cancer [<a href="#B6" id="i987h2908">6</a>,<a href="#B7" id="x903u7379">7</a>].
            </p>
            <p id="d1e135">Remarkable and certainly worth some scrutiny is the newly emerging information showing that the oestradiol&ndash;ER complex may
               not only control the survival of the breast cancer cell but also induce its death following exhaustive endocrine therapy.
               Until now, the only remaining option for the patient developing antihormonal resistance has been cytotoxic chemotherapy. Clinical
               studies [<a href="#B8" id="d814p5142">8</a>] demonstrate that the reintroduction of high-dose oestrogen following exhaustive endocrine therapy results in dramatic tumour
               responses. Laboratory studies also demonstrate that tumour regression can occur if physiological levels of oestrogen are used
               to treat long-term SERM resistance, and the few tumours that regrow are again responsive to tamoxifen treatment [<a href="#B9" id="m748j9726">9</a>]. The clinical question could soon become, 'Can low-dose oestrogen therapy be incorporated into the clinical treatment plan,
               cause tumour regression and reactivate antihormonal sensitivity?'
            </p>
            <p id="d1e143">If the mechanism of ER-mediated apoptosis is discovered, then this could improve response rates in breast cancer. Women with
               antihormone-resistant ER-positive tumours may respond to a cocktail of agents targeted at tyrosine kinases so that the ER
               becomes more central to survival. In other words, the aim would be to create multiple blocks to survival so that oestrogen-induced
               death becomes the only cellular option. Success here would double the response rate for endocrine treatment of breast cancer.
               If that were not enough, it would not be unreasonable to suggest that if the mechanism of ER-mediated apoptosis was discovered
               then it could open the door to innovation in targeted drugs for the death pathway of all cancer cells.
            </p>
            <p id="d1e145">Obviously, there is much to be done before we can begin to target the treatment of all ER-negative tumours, and it is reasonable
               to predict that issues of selectivity and systemic toxicity will be central to success. Nevertheless, who would have believed,
               when the principle of SERM action was established first in the laboratory and translated to the clinic, that this would act
               as the catalyst for the development of selective modulators for each member of the steroid receptor superfamily. Knowledge
               in one discipline can today be rapidly exported to enhance advances in other areas.
            </p>
            <p id="d1e147">The goal of <i id="j290f5291">Breast Cancer Research</i>'s new section on endocrinology and hormone therapy is not to replicate existing reviews in the endocrinology of breast cancer
               but to invigorate a new generation of investigators to take the lessons learned, whether they were good or bad, and apply
               the knowledge to new areas of investigation. The section will not necessarily provide answers but will instead aim to challenge
               our readers with novel concepts that might result in enhanced survival in breast cancer.
            </p>
         </div>
         <div class="section" id="h644s903"><a id="d1e152">
               <!-- named anchor --></a><h2 class="main-title" id="k640x7843">Competing interests</h2>
            <p id="d1e155">None declared.</p>
         </div>
         <div class="section" id="p731z1072"><a id="d1e157">
               <!-- named anchor --></a><h2 class="main-title" id="y305b8976">Abbreviations</h2>
            <p id="d1e160">ER = oestrogen receptor; HRT = hormone replacement therapy; SERM = selective oestrogen receptor modulator.</p>
         </div>
      </div>
      <div id="article1-back" class="back">
         <div class="back-section" id="t776d1521"><a id="d1e163">
               <!-- named anchor --></a><h2 class="main-title" id="a986n5490">References</h2>
            <div class="section ref-list" id="v609l3663"><a id="s35e6581">
                  <!-- named anchor --></a><div class="ref-list table" id="b221d9967">
                  <div class="row" id="f120q443">
                     <div class="ref-label cell" id="v628f7557">
                        <p class="ref-label" id="v478s6143"><span class="label" id="q47g3802"><span class="generated" id="a353t8602">1</span></span>&nbsp;<a id="B1">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="p895h998">
                        <p class="citation" id="p833b1839"><a id="d1e165">
                              <!-- named anchor --></a>Early Breast Cancer Trialists Collaborative Group<span class="ref-citation-article-title" id="t629f4766">Tamoxifen for early breast cancer: an overview of the randomised trials</span>  <span class="ref-citation-source" id="j275u2689">Lancet</span>.
                           	  <span class="ref-citation-year" id="r261n46">1998</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="d376b5650">9605801</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="r903q1514">10.1016/S0140-6736(97)11423-4</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="q718v8875">
                     <div class="ref-label cell" id="d701t3258">
                        <p class="ref-label" id="e254p9207"><span class="label" id="j323i3731"><span class="generated" id="n965d9497">2</span></span>&nbsp;<a id="B2">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="r129f4427">
                        <p class="citation" id="u564a1752"><a id="d1e186">
                              <!-- named anchor --></a><span class="ref-citation-name" id="k823v9161"><span class="ref-citation-surname" id="f36m7171">Jensen</span> <span class="ref-citation-given-name" id="v16i8681">EV.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z901b6447"><span class="ref-citation-surname" id="o345g1751">Jordan</span> <span class="ref-citation-given-name" id="z914v6055">VC.  
                                 	</span></span> <span class="ref-citation-article-title" id="i180b2896">The estrogen receptor: a model for molecular medicine. The Dorothy P. Landon AACR Prize for Translational Research</span>  <span class="ref-citation-source" id="k171f817">Clin Cancer Res</span>.
                           	  <span class="ref-citation-year" id="e441m8875">2003</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="k970z1412">12796359</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="a214v2230">
                     <div class="ref-label cell" id="b62x5356">
                        <p class="ref-label" id="n597b268"><span class="label" id="a486c7248"><span class="generated" id="t470x491">3</span></span>&nbsp;<a id="B3">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="s900b2923">
                        <p class="citation" id="c966n9352"><a id="d1e213">
                              <!-- named anchor --></a><span class="ref-citation-name" id="b10p9811"><span class="ref-citation-surname" id="v804j9103">Goss</span> <span class="ref-citation-given-name" id="b626f1479">PE.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z86w5393"><span class="ref-citation-surname" id="h754z2649">Strasser</span> <span class="ref-citation-given-name" id="u829o9238">K.  
                                 	</span></span> <span class="ref-citation-article-title" id="y347n2697">Aromatase inhibitors in the treatment and prevention of breast cancer</span>  <span class="ref-citation-source" id="p812y3158">J Clin Oncol</span>.
                           	  <span class="ref-citation-year" id="g411x244">2001</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="f539e4726">11157042</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="l560e1348">
                     <div class="ref-label cell" id="g500q451">
                        <p class="ref-label" id="v860i9688"><span class="label" id="a95f7594"><span class="generated" id="b261g593">4</span></span>&nbsp;<a id="B4">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="d695h2703">
                        <p class="citation" id="y41h4978"><a id="d1e240">
                              <!-- named anchor --></a>Writing Group for the Women's Health Initiative Investigators<span class="ref-citation-article-title" id="w181i6660">Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the women's health initiative
                              randomized controlled trial</span>  <span class="ref-citation-source" id="u646m2658">JAMA</span>.
                           	  <span class="ref-citation-year" id="f206z3990">2002</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="v531i340">12117397</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="p323m8773">10.1001/jama.288.3.321</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="p304b1340">
                     <div class="ref-label cell" id="n193h7144">
                        <p class="ref-label" id="x159e7318"><span class="label" id="f187i7182"><span class="generated" id="y867g6863">5</span></span>&nbsp;<a id="B5">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="q764f7259">
                        <p class="citation" id="h655x8573"><a id="d1e261">
                              <!-- named anchor --></a><span class="ref-citation-name" id="h486n9159"><span class="ref-citation-surname" id="p917r1797">Shumaker</span> <span class="ref-citation-given-name" id="i187m9568">SA.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="v678l3666"><span class="ref-citation-surname" id="o623q3231">Legault</span> <span class="ref-citation-given-name" id="w633r8280">C.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="a723h1631"><span class="ref-citation-surname" id="d862q448">Rapp</span> <span class="ref-citation-given-name" id="f41i1656">SR.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="h179f2333"><span class="ref-citation-surname" id="f880g3370">Thal</span> <span class="ref-citation-given-name" id="y966w669">L.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="j56m8315"><span class="ref-citation-surname" id="y754b8182">Wallace</span> <span class="ref-citation-given-name" id="a558v4080">RB.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="a676i425"><span class="ref-citation-surname" id="s324q5919">Ockene</span> <span class="ref-citation-given-name" id="o223o5100">JK.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="y549j8995"><span class="ref-citation-surname" id="x877u1714">Hendrix</span> <span class="ref-citation-given-name" id="v223e5089">SL.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="v1000v9445"><span class="ref-citation-surname" id="q672e8612">Jones</span> <span class="ref-citation-given-name" id="i990l7123">BN.  
                                 	</span>III</span>
                           	,
                           <span class="ref-citation-name" id="i27a1680"><span class="ref-citation-surname" id="i946x9067">Assaf</span> <span class="ref-citation-given-name" id="t505y9106">AR.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="g974t5600"><span class="ref-citation-surname" id="i742z7266">Jackson</span> <span class="ref-citation-given-name" id="t379o2993">RD.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="c135t536"><span class="ref-citation-surname" id="c342s4583">Kotchen</span> <span class="ref-citation-given-name" id="c646v5638">JM.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z969p1940"><span class="ref-citation-surname" id="r464z8447">Wassertheil-Smoller</span> <span class="ref-citation-given-name" id="x366f6858">S.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="n354w3646"><span class="ref-citation-surname" id="b631b255">Wactawski-Wende</span> <span class="ref-citation-given-name" id="g226h6195">J.  
                                 	</span></span> <span class="ref-citation-article-title" id="v738q2525">Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health
                              Initiative Memory Study: a randomized controlled trial</span>  <span class="ref-citation-source" id="z788a6833">JAMA</span>.
                           	  <span class="ref-citation-year" id="l160r2924">2003</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="s594j1327">12771112</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="y853h3358">10.1001/jama.289.20.2651</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="p860a2305">
                     <div class="ref-label cell" id="s635q9937">
                        <p class="ref-label" id="l284i9767"><span class="label" id="j452l9294"><span class="generated" id="m541y4201">6</span></span>&nbsp;<a id="B6">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="r124x36">
                        <p class="citation" id="x265g4887"><a id="d1e348">
                              <!-- named anchor --></a><span class="ref-citation-name" id="d690u6183"><span class="ref-citation-surname" id="v854t3195">Howell</span> <span class="ref-citation-given-name" id="i644m789">A.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="g939o3815"><span class="ref-citation-surname" id="q332u7263">Robertson</span> <span class="ref-citation-given-name" id="j65z4905">JFR.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="r19j6585"><span class="ref-citation-surname" id="x624d8709">Quaresma Albano</span> <span class="ref-citation-given-name" id="g995y4822">J.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="g102o6291"><span class="ref-citation-surname" id="r476j3853">Aschermannova</span> <span class="ref-citation-given-name" id="n606k9277">A.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="a315a1461"><span class="ref-citation-surname" id="m348n4380">Mauriac</span> <span class="ref-citation-given-name" id="z150m6126">L.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="n927a8389"><span class="ref-citation-surname" id="l231c7798">Kleeberg</span> <span class="ref-citation-given-name" id="u159o8746">UR.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="v859m973"><span class="ref-citation-surname" id="c257l1900">Vergot</span> <span class="ref-citation-given-name" id="c824m3208">I.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="b681k8421"><span class="ref-citation-surname" id="p980i3035">Erikstein</span> <span class="ref-citation-given-name" id="h713c9734">B.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="h786r8143"><span class="ref-citation-surname" id="d603w2614">Webster</span> <span class="ref-citation-given-name" id="x200b2082">A.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="t190o5143"><span class="ref-citation-surname" id="n355m5369">Morris</span> <span class="ref-citation-given-name" id="u953g5039">C.  
                                 	</span></span> <span class="ref-citation-article-title" id="d150j8789">Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing
                              after prior endocrine treatment</span>  <span class="ref-citation-source" id="w343l3802">J Clin Oncol</span>.
                           	  <span class="ref-citation-year" id="e659l5011">2002</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="s255k5172">12177099</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="y599z5108">10.1200/JCO.2002.10.057</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="l708e4218">
                     <div class="ref-label cell" id="x832k3875">
                        <p class="ref-label" id="j264h8108"><span class="label" id="w691n9768"><span class="generated" id="p785j4765">7</span></span>&nbsp;<a id="B7">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="j792b3866">
                        <p class="citation" id="x738w9907"><a id="d1e417">
                              <!-- named anchor --></a><span class="ref-citation-name" id="a595j9270"><span class="ref-citation-surname" id="m505l9490">Osborne</span> <span class="ref-citation-given-name" id="k464q4571">CK.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="y453t6132"><span class="ref-citation-surname" id="h336h7955">Pippen</span> <span class="ref-citation-given-name" id="r994y9945">J.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="s297w2480"><span class="ref-citation-surname" id="r512x8947">Jones</span> <span class="ref-citation-given-name" id="d759a2187">SE.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="k317l5904"><span class="ref-citation-surname" id="i607k5803">Parker</span> <span class="ref-citation-given-name" id="x402l2970">LM.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="r558f1852"><span class="ref-citation-surname" id="m774j3482">Ellis</span> <span class="ref-citation-given-name" id="f572t5112">M.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="l339e1665"><span class="ref-citation-surname" id="p439x8437">Come</span> <span class="ref-citation-given-name" id="v116i9019">S.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z301w5682"><span class="ref-citation-surname" id="u515c6367">Gertler</span> <span class="ref-citation-given-name" id="x364d5083">SZ.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="q632z6601"><span class="ref-citation-surname" id="j757f1428">May</span> <span class="ref-citation-given-name" id="h555i5150">JT.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="l362e8712"><span class="ref-citation-surname" id="c106r9676">Burton</span> <span class="ref-citation-given-name" id="g452o5064">G.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="q265f85"><span class="ref-citation-surname" id="g692d379">Dimery</span> <span class="ref-citation-given-name" id="l357j2633">I.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="f549p6954"><span class="ref-citation-surname" id="v430b9871">Webster</span> <span class="ref-citation-given-name" id="y539z5451">A.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="y889s8398"><span class="ref-citation-surname" id="q114y4039">Morris</span> <span class="ref-citation-given-name" id="z477d4768">C.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="v913f1075"><span class="ref-citation-surname" id="h137z6683">Elledge</span> <span class="ref-citation-given-name" id="m251y6915">R.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="k184z6117"><span class="ref-citation-surname" id="z563z2886">Buzdar</span> <span class="ref-citation-given-name" id="v580z141">A.  
                                 	</span></span> <span class="ref-citation-article-title" id="m795l8437">Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal
                              women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial</span>  <span class="ref-citation-source" id="b23d4865">J Clin Oncol</span>.
                           	  <span class="ref-citation-year" id="q882i3791">2002</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="f750l4304">12177098</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="w75s1793">10.1200/JCO.2002.10.058</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="g418a6135">
                     <div class="ref-label cell" id="z725c3064">
                        <p class="ref-label" id="q454u8375"><span class="label" id="n711n9295"><span class="generated" id="f315v6223">8</span></span>&nbsp;<a id="B8">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="j37g4510">
                        <p class="citation" id="f291m2872"><a id="d1e507">
                              <!-- named anchor --></a><span class="ref-citation-name" id="z143q4739"><span class="ref-citation-surname" id="c899u7051">Lonning</span> <span class="ref-citation-given-name" id="g763l4780">PE.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="r720h5573"><span class="ref-citation-surname" id="q322i7417">Taylor</span> <span class="ref-citation-given-name" id="v44t2030">PD.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="f121y7934"><span class="ref-citation-surname" id="g634z1952">Anker</span> <span class="ref-citation-given-name" id="y973r508">G.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="e809u6969"><span class="ref-citation-surname" id="u358x2617">Iddon</span> <span class="ref-citation-given-name" id="y535b674">J.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="x192t8486"><span class="ref-citation-surname" id="i690d2282">Wie</span> <span class="ref-citation-given-name" id="y300w9803">L.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="e516m4419"><span class="ref-citation-surname" id="z455i4141">Jorgensen</span> <span class="ref-citation-given-name" id="s147q2164">LM.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="p893q8660"><span class="ref-citation-surname" id="d774u2136">Mella</span> <span class="ref-citation-given-name" id="o608x8174">O.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="a417c7283"><span class="ref-citation-surname" id="p611i499">Howell</span> <span class="ref-citation-given-name" id="l924t5833">A.  
                                 	</span></span> <span class="ref-citation-article-title" id="y101t7320">High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy</span>  <span class="ref-citation-source" id="a281s4579">Breast Cancer Res Treat</span>.
                           	  <span class="ref-citation-year" id="l994t8145">2001</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="z526q1849">11519859</span>.
                           DOI:
                           	 <span class="ref-citation-doi" id="i663a2149">10.1023/A:1010619225209</span>.
                           
                        </p>
                     </div>
                  </div>
                  <div class="row" id="z413l9625">
                     <div class="ref-label cell" id="n196q9283">
                        <p class="ref-label" id="d405v6491"><span class="label" id="n343w5512"><span class="generated" id="h866g2344">9</span></span>&nbsp;<a id="B9">
                              <!-- named anchor --></a></p>
                     </div>
                     <div class="ref-content cell" id="y418m6392">
                        <p class="citation" id="c448y248"><a id="d1e566">
                              <!-- named anchor --></a><span class="ref-citation-name" id="h457s8646"><span class="ref-citation-surname" id="s754w673">Yao</span> <span class="ref-citation-given-name" id="d915a6765">K.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="j651u151"><span class="ref-citation-surname" id="g409o9307">Lee</span> <span class="ref-citation-given-name" id="k473i4021">ES.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="w746b9982"><span class="ref-citation-surname" id="k587g4081">Bentrem</span> <span class="ref-citation-given-name" id="s213q9999">DJ.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z371z4081"><span class="ref-citation-surname" id="m929m7748">England</span> <span class="ref-citation-given-name" id="c58b2704">G.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="z326a9226"><span class="ref-citation-surname" id="w505s7431">Schafer</span> <span class="ref-citation-given-name" id="k562b9528">JI.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="h768n183"><span class="ref-citation-surname" id="o818c5209">O'Regan</span> <span class="ref-citation-given-name" id="i86g7317">RM.  
                                 	</span></span>
                           	,
                           <span class="ref-citation-name" id="b198w7360"><span class="ref-citation-surname" id="v747f6057">Jordan</span> <span class="ref-citation-given-name" id="a667m2197">VC.  
                                 	</span></span> <span class="ref-citation-article-title" id="s8y4118">Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice</span>  <span class="ref-citation-source" id="r218l5946">Clin Cancer Res</span>.
                           	  <span class="ref-citation-year" id="i820r4307">2000</span>.
                           PMID:
                           	 <span class="ref-citation-pmid" id="l595l1904">10815929</span>.
                           
                        </p>
                     </div>
                  </div>
               </div>
            </div>
         </div>
      </div>
      <div id="article1-footer" class="footer">
         <hr class="part-rule" id="j839l5224"><div class="metadata" id="j966y8959">
            <h4 class="generated" id="p793k2911">Article Information (continued)</h4>
            <div class="metadata-group" id="i819k2976">
               <div class="metadata-area" id="c35j3801">
                  <p class="metadata-entry" id="q251u8019"><span class="generated" id="a399l675">Categories: </span></p>
                  <div class="metadata-chunk" id="g323c4838">
                     <p class="metadata-entry" id="z800w5200"><span class="generated" id="k220g5458">Subject: </span>Editorial
                     </p>
                  </div>
               </div>
               <div class="metadata-area" id="o126v8864">
                  <p class="metadata-entry" id="i766g1333"><span class="generated" id="i299n9832">Keywords: </span></p>
                  <div class="metadata-chunk" id="f728t1180">
                     <p class="metadata-entry" id="g414u3222"><span class="generated" id="m309m2526">Keyword: </span>antihormone
                     </p>
                     <p class="metadata-entry" id="m845a2734"><span class="generated" id="d149k6374">Keyword: </span>oestrogen receptor
                     </p>
                     <p class="metadata-entry" id="v565c9667"><span class="generated" id="j935n5985">Keyword: </span>selective oestrogen receptor modulation
                     </p>
                     <p class="metadata-entry" id="j347h1851"><span class="generated" id="x401b7451">Keyword: </span>tamoxifen
                     </p>
                  </div>
               </div>
            </div>
         </div>
         <hr class="part-rule" id="h253z7231"><div class="branding" id="a229g517">
            <p id="s243o4487">This display is generated from NISO JATS XML with <b id="v598w3686">jats-html.xsl</b>. The XSLT engine is SAXON 9.2.0.6 from Saxonica.
            </p>
         </div>
      </div>
   </body></html>
